These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 10528941)

  • 1. The long-term use of gabapentin, lamotrigine, and vigabatrin in patients with chronic epilepsy.
    Wong IC; Chadwick DW; Fenwick PB; Mawer GE; Sander JW
    Epilepsia; 1999 Oct; 40(10):1439-45. PubMed ID: 10528941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term retention rates of lamotrigine, gabapentin, and topiramate in chronic epilepsy.
    Lhatoo SD; Wong IC; Polizzi G; Sander JW
    Epilepsia; 2000 Dec; 41(12):1592-6. PubMed ID: 11114218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse event monitoring in lamotrigine patients: a pharmacoepidemiologic study in the United Kingdom.
    Wong IC; Mawer GE; Sander JW
    Epilepsia; 2001 Feb; 42(2):237-44. PubMed ID: 11240596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gabapentin versus lamotrigine monotherapy: a double-blind comparison in newly diagnosed epilepsy.
    Brodie MJ; Chadwick DW; Anhut H; Otte A; Messmer SL; Maton S; Sauermann W; Murray G; Garofalo EA;
    Epilepsia; 2002 Sep; 43(9):993-1000. PubMed ID: 12199724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of lamotrigine, vigabatrin and gabapentin as add-on therapy in intractable epilepsy of childhood.
    McDonald DG; Najam Y; Keegan MB; Whooley M; Madden D; McMenamin JB
    Seizure; 2005 Mar; 14(2):112-6. PubMed ID: 15694564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiepileptic drugs in development: prospects for the near future.
    Leppik IE
    Epilepsia; 1994; 35 Suppl 4():S29-40. PubMed ID: 8174517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of the lethargic (lh/lh) mouse model of absence seizures in predicting the effects of lamotrigine, vigabatrin, tiagabine, gabapentin, and topiramate against human absence seizures.
    Hosford DA; Wang Y
    Epilepsia; 1997 Apr; 38(4):408-14. PubMed ID: 9118845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The new antiepileptic drugs: a systematic review of their efficacy and tolerability.
    Marson AG; Kadir ZA; Hutton JL; Chadwick DW
    Epilepsia; 1997 Aug; 38(8):859-80. PubMed ID: 9579887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and interaction profile of topiramate: review and comparison with other newer antiepileptic drugs.
    Johannessen SI
    Epilepsia; 1997; 38 Suppl 1():S18-23. PubMed ID: 9092953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An audit of the new antiepileptic drugs in clinical neurological practice.
    McDonnell GV; Morrow JI
    Seizure; 1996 Jun; 5(2):127-30. PubMed ID: 8795128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refractory epilepsy: treatment with new antiepileptic drugs.
    Datta PK; Crawford PM
    Seizure; 2000 Jan; 9(1):51-7. PubMed ID: 10667964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of the safety of newer antiepileptic drugs.
    Shorvon S; Stefan H
    Epilepsia; 1997; 38 Suppl 1():S45-51. PubMed ID: 9092960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The outcome of prescribing novel anticonvulsants in an outpatient setting: factors affecting response to medication.
    Thijs RD; Kerr MP
    Seizure; 1998 Oct; 7(5):379-83. PubMed ID: 9808113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pharmacoepidemiologic study of factors influencing the outcome of treatment with lamotrigine in chronic epilepsy.
    Wong IC; Mawer GE; Sander JW; Lhatoo SD
    Epilepsia; 2001 Oct; 42(10):1354-8. PubMed ID: 11737172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic profile of topiramate in comparison with other new antiepileptic drugs.
    Perucca E
    Epilepsia; 1996; 37 Suppl 2():S8-S13. PubMed ID: 8641245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monostars: an aid to choosing an antiepileptic drug as monotherapy.
    Brodie MJ
    Epilepsia; 1999; 40 Suppl 6():S17-22; discussion S73-4. PubMed ID: 10530678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of four new antiepileptic medications.
    Collins TL; Petroff OA; Mattson RH
    Seizure; 2000 Jun; 9(4):291-3. PubMed ID: 10880292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of new antiepileptic drugs in the treatment of childhood epilepsy.
    Pellock JM; Appleton R
    Epilepsia; 1999; 40 Suppl 6():S29-38; discussion S73-4. PubMed ID: 10530681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New antiepileptic drugs for children: felbamate, gabapentin, lamotrigine, and vigabatrin.
    Devinsky O; Vazquez B; Luciano D
    J Child Neurol; 1994 Oct; 9 Suppl 1():S33-45. PubMed ID: 7822751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New antiepileptic drugs--an explosion of activity.
    Leach JP; Brodie MJ
    Seizure; 1995 Mar; 4(1):5-17. PubMed ID: 7788108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.